Reka E Pataky (Reka Pataky)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Combination Therapy

Health Insurance

Metastatic Colorectal Cancer

Top Venues

Current oncology (Toronto, Ont.)

PharmacoEconomics - open

PharmacoEconomics

MDM policy & practice

This page only lists publications with an associated author ORCID identifier.

Publications

Qi Guan, Suriya J Aktar, Reka E Pataky, Mariet Mathew Stephen, Maud Marques, Karen Gambaro, Kahina Rachedi, Katharina Forster, Samara Strub, David Stock, Louis de Léséleuc, Winson Y Cheung, Stuart J Peacock, Christie Farrer, Scott Gavura, Mina Tadrous, Robert C Grant, Kelvin K W Chan
Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada. Current oncology (Toronto, Ont.) 31 (6) (2024)
Qi Guan, Suriya J Aktar, Reka E Pataky, Mariet Mathew Stephen, Maud Marques, Karen Gambaro, Kahina Rachedi, Katharina Forster, Samara Strub, David Stock, Louis de Léséleuc, Winson Y Cheung, Stuart J Peacock, Christie Farrer, Scott Gavura, Mina Tadrous, Robert C Grant, Kelvin K W Chan
Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada. Current oncology (Toronto, Ont.) 31 (6) (2024)
Qi Guan, Suriya J Aktar, Reka E Pataky, Mariet Mathew Stephen, Maud Marques, Karen Gambaro, Kahina Rachedi, Katharina Forster, Samara Strub, David Stock, Louis de Léséleuc, Winson Y Cheung, Stuart J Peacock, Christie Farrer, Scott Gavura, Mina Tadrous, Robert C Grant, Kelvin K W Chan
Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada. Current oncology (Toronto, Ont.) 31 (6) (2024)
Wei Zhang, Daphne P Guh, Tima Mohammadi, Reka E Pataky, Alexander C T Tam, Larry D Lynd, Annalijn Ida Conklin
Health Care Costs Attributable to Prostate Cancer in British Columbia, Canada: A Population-Based Cohort Study. Current oncology (Toronto, Ont.) 30 (3) (2023)
Ria Garg, Eric C Sayre, Reka E Pataky, Helen McTaggart-Cowan, Stuart J Peacock, Jonathan M Loree, Michael McKenzie, Carl James Brown, Shirley S T Yeung, Mary A De Vera
Direct medical spending on young and average-age onset colorectal cancer before and after diagnosis: A population-based costing study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Reka E Pataky, Stirling Bryan, J Mark FitzGerald, Stuart J Peacock, Deirdre Weymann
Real-World Cost Effectiveness of a Policy of KRAS Testing to Inform Cetuximab or Panitumumab for Third-Line Therapy of Metastatic Colorectal Cancer in British Columbia, Canada. PharmacoEconomics - open (2023)
Wei Zhang, Daphne P Guh, Tima Mohammadi, Reka E Pataky, Alexander C T Tam, Larry D Lynd, Annalijn Ida Conklin
Health Care Costs Attributable to Prostate Cancer in British Columbia, Canada: A Population-Based Cohort Study. Current oncology (Toronto, Ont.) 30 (3) (2023)
Wei Zhang, Daphne P Guh, Tima Mohammadi, Reka E Pataky, Alexander C T Tam, Larry D Lynd, Annalijn Ida Conklin
Health Care Costs Attributable to Prostate Cancer in British Columbia, Canada: A Population-Based Cohort Study. Current oncology (Toronto, Ont.) 30 (3) (2023)
Wei Fang Dai, Claire de Oliveira, Scott Blommaert, Reka E Pataky, David Tran, Zeb Aurangzeb, Cynthia Kendell, Chris Folkins, Chandy Somayaji, Jeff Dowden, Winson Cheung, Erin Strumpf, Jaclyn M Beca, Carol McClure, Robin Urquhart, James Ted McDonald, Riaz Alvi, Donna Turner, Stuart Peacock, Avram E Denburg, Rebecca E Mercer, Caroline Muñoz, Ambica Parmar, Mina Tadrous, Pam Takhar, Kelvin K W Chan, null On Behalf Of The CanREValue Collaboration
Mapping Canadian Data Assets to Generate Real-World Evidence: Lessons Learned from Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration's RWE Data Working Group. Current oncology (Toronto, Ont.) 29 (3) (2022)
Reka E Pataky, Stirling Bryan, J Mark FitzGerald, Stuart J Peacock, Deirdre Weymann
Tools for the Economic Evaluation of Precision Medicine: A Scoping Review of Frameworks for Valuing Heterogeneity-Informed Decisions. PharmacoEconomics 40 (10) (2022)
Reka E Pataky, Jaclyn Beca, David Tran, Wei Fang Dai, Erind Dvorani, Wanrudee Isaranuwatchai, Stuart Peacock, Riaz Alvi, Winson Y Cheung, Craig C Earle, Scott Gavura, Kelvin Kar-Wing Chan
Real-World Cost-Effectiveness of Bevacizumab With First-Line Combination Chemotherapy in Patients With Metastatic Colorectal Cancer: Population-Based Retrospective Cohort Studies in Three Canadian Provinces. MDM policy & practice 6 (1) (2021)